| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0035 | 0.9 |